Vevo Therapeutics Funding Round

12/8/2022

Venture Equity

$12,000,000

Undisclosed

The company intends to use the funds to accelerate growth and expand operations.

Private & Independent

Biopharmaceutical

953 Indiana St
San Francisco, CA 94107
USA

Undisclosed

Vevo Therapeutics is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company's Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Vevo is using Mosaic to build the world's largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies.